284 related articles for article (PubMed ID: 18837946)
21. Circulating nucleosomes and cytokeratin 19-fragments in patients with colorectal cancer during chemotherapy.
Holdenrieder S; Holubec L; Topolcan O; Finek J; Stieber P
Anticancer Res; 2005; 25(3A):1795-801. PubMed ID: 16033102
[TBL] [Abstract][Full Text] [Related]
22. Hyaluronic acid as prognostic marker in resectable colorectal cancer.
Llaneza A; Vizoso F; Rodríguez JC; Raigoso P; García-Muñiz JL; Allende MT; García-Morán M
Br J Surg; 2000 Dec; 87(12):1690-6. PubMed ID: 11122186
[TBL] [Abstract][Full Text] [Related]
23. Quantification of circulating DNA in the plasma and serum of cancer patients.
Taback B; O'Day SJ; Hoon DS
Ann N Y Acad Sci; 2004 Jun; 1022():17-24. PubMed ID: 15251934
[TBL] [Abstract][Full Text] [Related]
24. Effect of adjuvant chemotherapy on integrity of free serum DNA in patients with breast cancer.
Deligezer U; Eralp Y; Akisik EZ; Akisik EE; Saip P; Topuz E; Dalay N
Ann N Y Acad Sci; 2008 Aug; 1137():175-9. PubMed ID: 18837944
[TBL] [Abstract][Full Text] [Related]
25. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.
Schwarzenbach H; Alix-Panabières C; Müller I; Letang N; Vendrell JP; Rebillard X; Pantel K
Clin Cancer Res; 2009 Feb; 15(3):1032-8. PubMed ID: 19188176
[TBL] [Abstract][Full Text] [Related]
26. Quantification of LINE1 in circulating DNA as a molecular biomarker of breast cancer.
Sunami E; Vu AT; Nguyen SL; Giuliano AE; Hoon DS
Ann N Y Acad Sci; 2008 Aug; 1137():171-4. PubMed ID: 18837943
[TBL] [Abstract][Full Text] [Related]
27. Integrity of cell-free plasma DNA in patients with lung cancer and nonmalignant lung disease.
Schmidt B; Weickmann S; Witt C; Fleischhacker M
Ann N Y Acad Sci; 2008 Aug; 1137():207-13. PubMed ID: 18837948
[TBL] [Abstract][Full Text] [Related]
28. Deoxyribonuclease activity and circulating DNA concentration in blood plasma of patients with prostate tumors.
Cherepanova AV; Tamkovich SN; Bryzgunova OE; Vlassov VV; Laktionov PP
Ann N Y Acad Sci; 2008 Aug; 1137():218-21. PubMed ID: 18837950
[TBL] [Abstract][Full Text] [Related]
29. Utility of serum preoperative carcinoemberyonic antigen in colorectal cancer patients.
El-Awady S; Lithy R; Morshed M; Khafagy W; Abd Monem H; Waleed O; Badr S; Fekry A; El Nakeeb A; Ghazy H; El Yamany M; Metwally T; El-Arman M; Farid M
Hepatogastroenterology; 2009; 56(90):361-6. PubMed ID: 19579599
[TBL] [Abstract][Full Text] [Related]
30. Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer.
Herbst A; Rahmig K; Stieber P; Philipp A; Jung A; Ofner A; Crispin A; Neumann J; Lamerz R; Kolligs FT
Am J Gastroenterol; 2011 Jun; 106(6):1110-8. PubMed ID: 21326223
[TBL] [Abstract][Full Text] [Related]
31. Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer.
Roessler M; Rollinger W; Palme S; Hagmann ML; Berndt P; Engel AM; Schneidinger B; Pfeffer M; Andres H; Karl J; Bodenmüller H; Rüschoff J; Henkel T; Rohr G; Rossol S; Rösch W; Langen H; Zolg W; Tacke M
Clin Cancer Res; 2005 Sep; 11(18):6550-7. PubMed ID: 16166432
[TBL] [Abstract][Full Text] [Related]
32. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
33. Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer.
Gallego R; Codony-Servat J; García-Albéniz X; Carcereny E; Longarón R; Oliveras A; Tosca M; Augé JM; Gascón P; Maurel J
Endocr Relat Cancer; 2009 Mar; 16(1):311-7. PubMed ID: 19109398
[TBL] [Abstract][Full Text] [Related]
34. Cell-free circulating DNA: Diagnostic value in patients with renal cell cancer.
Hauser S; Zahalka T; Ellinger J; Fechner G; Heukamp LC; VON Ruecker A; Müller SC; Bastian PJ
Anticancer Res; 2010 Jul; 30(7):2785-9. PubMed ID: 20683013
[TBL] [Abstract][Full Text] [Related]
35. DNA image cytometry predicts disease outcome in stage II colorectal carcinoma.
Buhmeida A; Hilska M; Elzagheid A; Laato M; Collan Y; Syrjänen K; Pyrhönen S
Anticancer Res; 2009 Jan; 29(1):99-106. PubMed ID: 19331138
[TBL] [Abstract][Full Text] [Related]
36. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
37. Metallopanstimulin as a novel tumor marker in sera of patients with various types of common cancers: implications for prevention and therapy.
Fernandez-Pol JA
Anticancer Res; 1996; 16(4B):2177-85. PubMed ID: 8694540
[TBL] [Abstract][Full Text] [Related]
38. Serum matrilysin levels predict outcome in curatively resected colorectal cancer patients.
Martínez-Fernandez A; García-Albeniz X; Pineda E; Visa L; Gallego R; Codony-Servat J; Augé JM; Longarón R; Gascón P; Lacy A; Castells A; Maurel J
Ann Surg Oncol; 2009 May; 16(5):1412-20. PubMed ID: 19259740
[TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of mesenteric and peripheral blood circulating tumor DNA in colorectal cancer patients.
Taback B; Saha S; Hoon DS
Ann N Y Acad Sci; 2006 Sep; 1075():197-203. PubMed ID: 17108212
[TBL] [Abstract][Full Text] [Related]
40. Preoperative serum vascular endothelial growth factor-a is a marker for subsequent recurrence in colorectal cancer patients.
Alabi AA; Suppiah A; Madden LA; Monson JR; Greenman J
Dis Colon Rectum; 2009 May; 52(5):993-9. PubMed ID: 19502868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]